• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含磺胺类药物与琥乙红霉素复方口服混悬剂的分析

Analysis of oral suspensions containing sulfonamides in combination with erythromycin ethylsuccinate.

作者信息

Elrod L, Cox R D, Plasz A C

出版信息

J Pharm Sci. 1982 Feb;71(2):161-6. doi: 10.1002/jps.2600710206.

DOI:10.1002/jps.2600710206
PMID:6977637
Abstract

The sulfonamides and erythromycin ethylsuccinate in combination oral suspensions were determined by high-performance liquid chromatography and automated turbidimetry, respectively. The chromatographic procedure was rapid, specific, and stability-indicating for sulfisoxazole acetyl and the trisulfapyrimidines using a reversed-phase system with UV detection at 254 nm. Erythromycin ethylsuccinate did not interfere with the sulfonamide analysis and these compounds were assayed with relative standard deviations (RDS) ranging from +/- 2.1 to +/- 3.1%. Erythromycin ethylsuccinate was determined as erythromycin with RSD values of +/- 1.3 or 3.5% without interference by the sulfonamides present.

摘要

分别采用高效液相色谱法和自动比浊法测定复方口服混悬剂中的磺胺类药物和琥乙红霉素。色谱方法快速、特异,对于乙酰磺胺异恶唑和三磺胺嘧啶,使用反相系统在254nm处进行紫外检测,具有稳定性指示作用。琥乙红霉素不干扰磺胺类药物的分析,这些化合物的测定相对标准偏差(RDS)为±2.1%至±3.1%。琥乙红霉素以红霉素计进行测定,相对标准偏差(RSD)值为±1.3%或3.5%,不受共存磺胺类药物的干扰。

相似文献

1
Analysis of oral suspensions containing sulfonamides in combination with erythromycin ethylsuccinate.含磺胺类药物与琥乙红霉素复方口服混悬剂的分析
J Pharm Sci. 1982 Feb;71(2):161-6. doi: 10.1002/jps.2600710206.
2
High-performance liquid chromatographic assay of erythromycin and its esters using electrochemical detection.采用电化学检测法对红霉素及其酯类进行高效液相色谱分析。
J Chromatogr. 1987 Aug 7;419:205-12. doi: 10.1016/0378-4347(87)80278-5.
3
Fluorimetric determination of erythromycin and erythromycin ethylsuccinate in serum by a high-performance liquid chromatographic post-column, on-stream derivatization and extraction method.高效液相色谱柱后在线衍生化萃取法荧光测定血清中的红霉素和琥乙红霉素
J Chromatogr. 1978 Oct 1;158:337-48. doi: 10.1016/s0021-9673(00)89978-1.
4
Determination of erythromycin and related substances in enteric-coated tablet formulations by reversed-phase liquid chromatography.采用反相液相色谱法测定肠溶片制剂中红霉素及相关物质。
J Pharm Sci. 2000 Sep;89(9):1097-105. doi: 10.1002/1520-6017(200009)89:9<1097::aid-jps1>3.0.co;2-d.
5
Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.通过高压液相色谱法测定依托红霉素相对于琥乙红霉素的药代动力学优势。
Antimicrob Agents Chemother. 1988 Apr;32(4):561-5. doi: 10.1128/AAC.32.4.561.
6
[Stability of tablet formulation containing erythromycin ethylsuccinate and demeclocycline hydrochloride].[含琥乙红霉素和盐酸地美环素的片剂制剂稳定性]
Boll Chim Farm. 1983 Feb;122(2):109-17.
7
Determination of erythromycin ethylsuccinate by liquid chromatography.液相色谱法测定琥乙红霉素
J Chromatogr. 1992 May 27;600(1):99-108. doi: 10.1016/0021-9673(92)85443-w.
8
[Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
Pharmazie. 1995 Jan;50(1):56-60.
9
Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
J Clin Pharmacol. 1985 Jan-Feb;25(1):36-42. doi: 10.1002/j.1552-4604.1985.tb02798.x.
10
Simultaneous determination of erythromycin ethylsuccinate and its metabolite erythromycin in human plasma using liquid chromatography-electrospray ionization mass spectrometry for clinical study.采用液相色谱-电喷雾电离质谱法同时测定人血浆中琥乙红霉素及其代谢产物红霉素用于临床研究。
J Pharm Biomed Anal. 2006 Feb 24;40(3):737-43. doi: 10.1016/j.jpba.2005.11.005. Epub 2006 Jan 10.